Mitigation and management of adverse events associated with amivantamab therapy
- DOI
- 10.1093/oncolo/oyaf194
- Published
- 2025-07
- Container
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/oncolo/oyaf194,
title = {Mitigation and management of adverse events associated with amivantamab therapy},
author = {Narjust Florez and Nicole R LeBoeuf and Julia Rotow and Jennifer A Marks and Joshua K Sabari and Oscar Arrieta and Clarissa Baldotto and Rahul Gosain and Dianne Zawisza and Stephanie McDonald and Emanuela Dylgjeri and Paul Cifuentes and Beth McLellan and Natasha B Leighl},
year = {2025},
journal = {The Oncologist},
doi = {10.1093/oncolo/oyaf194},
url = {https://doi.org/10.1093/oncolo/oyaf194}
}RIS
TY - JOUR TI - Mitigation and management of adverse events associated with amivantamab therapy AU - Narjust Florez AU - Nicole R LeBoeuf AU - Julia Rotow AU - Jennifer A Marks AU - Joshua K Sabari AU - Oscar Arrieta AU - Clarissa Baldotto AU - Rahul Gosain AU - Dianne Zawisza AU - Stephanie McDonald AU - Emanuela Dylgjeri AU - Paul Cifuentes AU - Beth McLellan AU - Natasha B Leighl PY - 2025 JO - The Oncologist DO - 10.1093/oncolo/oyaf194 UR - https://doi.org/10.1093/oncolo/oyaf194 ER -
APA
Florez, N., LeBoeuf, N. R., Rotow, J., Marks, J. A., Sabari, J. K., Arrieta, O., Baldotto, C., Gosain, R., Zawisza, D., McDonald, S., Dylgjeri, E., Cifuentes, P., McLellan, B., & Leighl, N. B. (2025). Mitigation and management of adverse events associated with amivantamab therapy. The Oncologist. https://doi.org/10.1093/oncolo/oyaf194
Source records
- crossref · retrieved 2026-09-26T06:44:31.288Z